Profiling of hepatocellular miRNA carried by circulating hepatitis B virus surface antigen particles: a non invasive tool to identify clinically relevant miRNA signaturesElena ProvasiMinistero della Salute (Ricerca Finalizzata)
Analysis of the role of different isoforms of thymic stromal lymphopoietin and the microbiota in T cell activation in inflammatory conditions of the gutJens GeginatMinistero della Salute (Ricerca Finalizzata)
Development of high throughput, integrated and costeffective molecular diagnostic tests for the detection of genetic and epigenetic defects involved in human diseaseMassimiliano PaganiMinistero della Salute (Ricerca Finalizzata)
GENome wide association study to Evaluate genetic risk factors for cerebral sinus venous thromboSIS (GENESIS Study)Sergio AbrignaniMinistero della Salute (Ricerca Finalizzata)
Identification of common pathways that drive the metastatic disease through miRNA profiling of transgenic mouse models and human cancersValentina Vaira / Elena ProvasiMinistero della Salute (Giovani Ricercatori)
Molecular and functional characterization of Th17 cell populations in the gutJens GeginatMinistero della Salute (Giovani Ricercatori)
Targeting the MYC chromatin interaction network in Cancer Stem CellsAlessio ZippoMinistero della Salute (Giovani Ricercatori)
Dissecting the epigenetic landscape of rhabdomyosarcoma: role of p38alpha kinase in the control of Polycomb Repressive Complex 2Beatrice BodegaMinistero della Salute (Giovani Ricercatori)
Serum microRNAs released by human CD4+ T cell subsets as biomarkers of vaccine efficacy and adverse eventsSergio Abrignani / Paola de CandiaInstitut Merieux (Merieux Research Grant)
nuc-inositide— Investigating the topography of nuclear phosphoinositide signalling in relation to chromatin and the genomeNullin DivechaUnione Europea (Marie Curie IEF)
Modulation of anti-cancer immune response by regulatory non-coding RNAsMassimiliano PaganiFONDAZIONE CARIPLO
T cell RNA signatures in inflammatory bowel diseasesJens GeginatFONDAZIONE CARIPLO
Modulation of Eukaryotic Initiation Factor 6 Activity as a Therapeutic Tool in Ribosome-Based Disease Stefano BiffoTelethon
Translational control in cancer: targeting of eIF6 and mTOR independent pathwaysStefano BiffoAIRC